Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Jacques Morel26
Drug-Related Side Effects and Adverse Reactions (epidemiology)1
Jacques Morel Sauf Drug-Related Side Effects and Adverse Reactions (epidemiology)" 25
Drug-Related Side Effects and Adverse Reactions (epidemiology) Sauf Jacques Morel" 0
Jacques Morel Et Drug-Related Side Effects and Adverse Reactions (epidemiology) 1
Jacques Morel Ou Drug-Related Side Effects and Adverse Reactions (epidemiology) 26
Corpus758
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000187 William Terreaux [France] ; Claire Masson [France] ; Jean-Paul Eschard [France] ; Thomas Bardin [France] ; Arnaud Constantin [France] ; Loïc Le Dantec [France] ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean-Hugues Salmon [France]Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021